Renal Angioplasty and Stenting Under Protection: The Way for the Future?

Catheterization and Cardiovascular Interventions

Volumn 60, Issue 3, 2003, Pages 299-312

  Henry, Michel ^a,d   Henry, Isabelle ^d   Klonaris, Christos ^d   Polydorou, Antonio ^b   Rath, Pathrap ^a   Lakshmi, Gopalakrishnan ^a   Rajacopal, Sriram ^c   Hugel, Michèle ^a  

^a Maharashtra   (India)

^b IASO GENERAL HOSPITAL   (Greece)

^c Southern Railway Hospital India   (India)

^d NONE

Author keywords

Angioplasty; Hypertension; Protection devices; Renal artery; Renal insufficiency; Stent

Indexed keywords

CREATININE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD PRESSURE; CAROTID ARTERIOGRAPHY; CREATININE BLOOD LEVEL; DEVICE; DIASTOLIC BLOOD PRESSURE; EMBOLISM; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; RENAL ARTERY ANGIOPLASTY; SAFETY; STENT; SYSTOLIC BLOOD PRESSURE; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; BALLOON OCCLUSION; BLOOD PRESSURE; BLOOD VESSEL PROSTHESIS IMPLANTATION; DEVICE REMOVAL; DIASTOLE; EQUIPMENT SAFETY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY FAILURE; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL ARTERY OBSTRUCTION; STENTS; SYSTOLE; TREATMENT OUTCOME; VASODILATION;

EID: 0242385593     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10669     Document Type: Article

References (62)

1. Berglund G, Anderson O, Wilhelmsent. Prevalence of primary and secondary hypertension studies in a random population sample. Br Med J 1976;2:554-556.
2. Novick AC. Options for therapy of ischemic nephropathy: role of angioplasty and surgery. Semin Nephrol 1996;16:53-60.
3. Zuccala A, Zucchelli P. Ischemic nephropathy: diagnosis and treatment. J Nephrol 1998;11:318-324.
4. Klinge J, Mali PTM, Puijlaert CBA, et al. Percutaneous transluminal renal angioplasty: initial and long-term results. Radiology 1989;171:501-506.
5. Canzanello VJ, Millan VG, Spiegel JE, et al. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension 1989;13:163-172.
6. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983;309:274-279.
7. Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282-286.
8. Henry M, Amor M, Henry I, et al. Stents in the treatment of renal artery stenosis: long term follow-up. J Endovasc Surg 1999;6:42-51.
9. Henry M, Amor M, Henry I, et al. Stent placement in the renal artery: three-year experience with the Palmaz stent. J Vasc Intervent Radiol 1996;7:343-350.
10. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal artery stenosis with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-465.
11. Iannone LA, Underwood P, Nath A, et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function and balloon pressure in hypertension and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn 1996;37:243-250.
12. Von Knorring J, Edgren J, Lepantalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol 1996;37:36-40.
13. Kuhlmann U, Greminger A, et al. Long-term experience in percutaneous transluminal dilatation of renal artery stenosis. Am J Med 1985;79:692-698.
14. Dorros G, Jaff M, Jain A, et al. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995;75:1051-1055.
15. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 1999;92:159-167.
16. Boisclair C, Therasse E, Olivia VL, et al. Treatment of renal angioplasty failure by perculaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. Am J Roentgenol 1997;168:245-251.
17. Van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atheosclerotic renal artery stenosis. Lancet 1995;346:672-674.
18. Wilms G, Staessen J, Baert AL, et al. Percutaneous transluminal renal angioplasty and renal function. Radiology 1989;29:195-200.
19. Wilms GE, Peene PT, Baert AL, et al. Renal artery stent placement with use of the Wallstent endoprosthesis. Radiology 1991;179:457-462.
20. Henry M, Kconaris C, Henry I. Renal stenting with the PercuSurge GuardWire device: a pilot study. J Endovasc Ther 2001;8:227-237
21. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. Guidelines for percutaneous transluminal angioplasty. Radiology 1990;177:619-626.
22. Dorros G, Jaff M, Mathiak L, et al. Four year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-647.
23. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mays Clin Proc 2002;77:309-316.
24. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984;11:383-392.
25. Srandness DE Jr. Natural history of renal artery stenosis. Am J Kidney Dis 1994;24:630-635.
26. Zierler RE. Screening for renal artery stenosis: is it justified. Mayo Clin Proc 2002;77:307-308.
27. White CJ. Open renal arteries are better than closed renal arteries. Cathet Cardiovasc Diagn 1998;45:9-10.
28. Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease: ten years' experience. JAMA 1987;257:498-501.
29. Weibull H, Bergqvist D, Bergentz SE, et al. PTRA versus surgical reconstruction of atherosclerotic renal stenosis: a prospective randomized study. J Vasc Surg 1993;18:841-852.
30. Cambria RP. Surgery: indications and variables that affect procedural outcome, as well as morbidity and mortality. J Invas Cardiol 1998;10:55-58.
31. Dorros G, Prince C, Mathia KL, et al. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn 1993;29:191-198.
32. Zeller TH. Endovascular treatment of renal artery stenosis: technical aspects-long term clinical results and restenosis rate. Paris: Course Revascularization Book; 2000. p 333-364.
33. Rocha Sing KJ, Miskkel GJ, Kathodi RE, et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Cathet Cardiovasc Intervent 1999;47:167-172.
34. Taylor A, Sheppard D, Macleod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol 1997;52:451-457.
35. Paulsen D, Klow NE, Rogstad B, et al. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease. Nephrol Dial Transplant 1999;14:1454-1456.
36. Rodriguez-Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome in 108 patients. J Vasc Surg 1999;29:617-624.
37. Harden PN, MacLeaod MJ, Rodger RSC, Baxter GM, Connell JMC, Dominiczak AF, Junor BJR, Briggs JD, Moss J. Effect on renal-artery stenting on progression of renovascular renal failure. Lancet 1997;349:1133-1136.
38. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;4:622-629.
39. Durros G. Long-term effects of stent revascularization upon blood pressure management renal function and patient survival. J Invas Cardiol 1998;10:51-53.
40. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 1999;92:159-167.
41. Subramanian R, Silva JA, Ramec SR, et al. Beneficial effects of chronic renal insufficiency. Eur Heart J 2002;97:577.
42. Guerrero, Kunjmmen B, Khaleel R, et al. Stabilization of renal function after renal artery stenting. Am J Cardiol 2002;90:63H.
43. Scolari F, Bracchi M, Valzorio B, et al. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Trasplant 1996;11:1607-1612.
44. Meyrier A. Renal vascular lesions in the elderly: nephrosclerosis or atheromatous renal disease? Nephrol Dial Transplant 1996;11(Suppl 9):45-52.
45. Saleem S, Lakkis FG, Martinez-Maldonado M. Atheroembolic renal disease. Semin Nephrol 1996;16:309-318.
46. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med 1996;100:524-529.
47. Walker C, Kowalski J, Knan M, et al. Proximal protection before distal protection: preventing large atheroemboly during renal intervention. Am J Cardiol 2002;90:28H.
48. Rauh G, Spengel FA. Blue toe syndrome after initiation of low-dose anticoagulation. Eur J Med Res 1998;3:278-280.
49. Belenfant X, d'Auzac C, Bariety J, et al. Cholesterol crystal embolism during treatment with low-molecular-weight heparin. Presse Med 1997;26:1236-1237.
50. Commeau P, Barragan P, Huret B, et al. Direct stenting in the treatment of renal artery stenosis: immediate and in-hospital results. Am J Cardiol 2001;TCT74.
51. Morice MC, Marcoj, Laborde JC, et al. The French registry on renal stenting. Am J Cardiol 2002;90:67H.
52. Thadani RI, Camargo CA Jr, Xavier RJ, et al. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Med (Balt) 1995;74:350-358.
53. Haqqie SS, Urizar RE, Singh J. Nephrotic-range proteinuria in renal atheroembolic disease: report of four cases. Am J Kidney Dis 1996;28:493-501.
54. Greenberg A, Bastacky SI, Iqbal A, et al. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am J Kidney Dis 1997;29:334-344.
55. Krishnamurthi V, Novick AC, Myles JL. Atheroembolic renal disease: effect on morbidity and survival after renovascularization for atherosclerotic renal artery stenting. Cathet Cardiovasc Intervent 1999;46:245-248.
56. Boero R, Borcam M, Ladarola GM, et al. Acute kidney failure caused by cholesterol embolism. Minerva Urol Nephrol 2000;52:119-122.
57. Hasegawa M, Kawashima S, Shikano M, et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of cholesterol embolic disease: a report of 5 cases. Am J Nephrol 2000;20:263-267.
58. Kammerl MC, Fishereder M, Zulke C, et al. Renal transplantation in a patient and stage renal disease due to cholesterol embolism. Transplantation 2001;71:149-151.
59. Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Cathet Cardiovasc Intervent 1999;46:245-248.
60. Henry M, Henry I, Klonaris C, et al. Benefits of cerebral protection during carotid stenting with the percusurge GuardWire system: midterm results. J Endovasc Ther 2002;9:1-13.
61. Reimers B, Corvaja N, Moshiris, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001;104:12-15.
62. Roubin GS. Carotid angioplasty and stenting under cerebral protection: the standard of care. Scottsdole: International Congress 15;11-14 February 2002.